Nakagawa K, Garon EB, Gao L, Callies S, et al. RELAY, ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR-mutated metastatic non-small cell lung cancer: exposure-response relationship. Cancer Chemother Pharmacol 2022 Jul 16. pii: 10.1007/s00280-022-04447.
PMID: 35841410